![]() |
Volumn 3, Issue 2, 1996, Pages 57-59
|
Estrogen replacement therapy for the breast cancer survivor
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ESTROGEN;
ESTROGEN RECEPTOR;
ORAL CONTRACEPTIVE AGENT;
TAMOXIFEN;
BREAST CANCER;
CANCER RECURRENCE;
CANCER SURVIVAL;
ESTROGEN THERAPY;
HORMONE SUBSTITUTION;
ISCHEMIC HEART DISEASE;
MORTALITY;
OSTEOPOROSIS;
PREGNANCY;
PRIORITY JOURNAL;
REVIEW;
SURVIVAL RATE;
TUMOR GROWTH;
ADOLESCENT;
ADULT;
ANTICARCINOGENIC AGENTS;
BREAST NEOPLASMS;
ESTROGEN REPLACEMENT THERAPY;
FEMALE;
HUMANS;
MIDDLE AGED;
PREGNANCY;
PROGNOSIS;
RECEPTORS, ESTROGEN;
RECURRENCE;
SURVIVORS;
TAMOXIFEN;
|
EID: 0030051395
PISSN: 10715576
EISSN: None
Source Type: Journal
DOI: 10.1016/1071-5576(95)00056-9 Document Type: Article |
Times cited : (3)
|
References (10)
|